Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-P Farcy Jacquet

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2008
[Documentation management: from theory to practice]I Barillot, S Chapet, M-P Farcy Jacquet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2019
[Treatment of oligometastatic or oligoprogression cancer]C Bourgier, I Latorzeff, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2019
[Individual modification of the dose, volume and fractionation of breast radiotherapy]C Bourgier, C Lemanski, R Draghici, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2019
[Predictive assays for responses of tumors and normal tissues in radiation oncology]O Riou, C Bourgier, M Brengues, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2008
[Documentation management: from theory to practice]I Barillot, S Chapet, M-P Farcy Jacquet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2019
[Treatment of oligometastatic or oligoprogression cancer]C Bourgier, I Latorzeff, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2019
[Individual modification of the dose, volume and fractionation of breast radiotherapy]C Bourgier, C Lemanski, R Draghici, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2019
[Predictive assays for responses of tumors and normal tissues in radiation oncology]O Riou, C Bourgier, M Brengues, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Pageof 1